{
    "clinical_study": {
        "@rank": "129584", 
        "acronym": "LOAD", 
        "arm_group": [
            {
                "arm_group_label": "Intervention", 
                "arm_group_type": "Active Comparator", 
                "description": "The loading dose of 300 000 IU is divided into three doses (100 000 IU) and will be given over the first months. All patients in the intervention group will receive the first loading dose of 100 000 IU at day of discharge. The second (2 weeks) and third (4 weeks postoperative) administration will be given based on the 25-hydroxy vitamin D concentration. After the last respectively third loading dose a maintenance dose of 3420 IU per day should maintain the high 25-hydroxy vitamin D concentration. It should be administered for up to 46 weeks (until follow-up visit)"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "The placebo loading dose (oil) is divided into three administrations and will be given over the first months. All patients in the placebo group will receive the first placebo loading dose at day of discharge. After the last placebo loading dose a maintenance dose of 3420 IU per day should maintain the 25-hydroxy vitamin D concentration. It should be administered for up to 46 weeks (until follow-up)."
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of the study is to increase vitamin D concentrations or to keep it on high level,\n      respectively, by supplementing with vitamin D3 in a different dose regime, and to improve\n      the overall health status in bariatric patients. In this project, the vitamin D status, the\n      parameters of inflammation, bone turnover, insulin resistance, liver and depression score of\n      bariatric patients are expected to improve, due to supplementation of a loading dose\n      compared to the standard therapy."
        }, 
        "brief_title": "The Link Between Obesity And Vitamin D in Bariatric Patients With Omega-loop Bypass Surgery", 
        "completion_date": {
            "#text": "July 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Bariatric Surgery Candidate", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Planned omega loop bypass surgery\n\n          -  25-hydroxy vitamin D < 75 nmol/l\n\n          -  BMI >40 or \u226535 kg/m2 with co-morbidities e.g. diabetes mellitus, hypertension\n\n          -  Body weight <140 kg (due to limitation of DEXA measurement)\n\n          -  Capability to consent\n\n        Exclusion Criteria:\n\n          -  Another planned form of bariatric surgery\n\n          -  Hypercalcemia (calcium >2.63 mmol/l) or hypocalcemia (<1.75 mmol/l)\n\n          -  Renal insufficiency (creatinine >133 \u03bcmol/l or GFR <50 ml/min)\n\n          -  Primary hyperparathyroidism\n\n          -  Malignancy\n\n          -  Infection e.g. human immunodeficiency virus\n\n          -  Medical conditions requiring daily calcium supplements or antacid use\n\n          -  Known hypersensitivity to cholecalciferol\n\n          -  No capability to consent\n\n          -  Imprisoned persons"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 17, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02092376", 
            "org_study_id": "LOAD", 
            "secondary_id": "2013-003546-16"
        }, 
        "intervention": [
            {
                "arm_group_label": "Intervention", 
                "intervention_name": "Cholecalciferol", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Cholecalciferol", 
                "Vitamin D", 
                "Ergocalciferols", 
                "Vitamins"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Bariatric surgery", 
            "vitamin D", 
            "supplementation"
        ], 
        "lastchanged_date": "March 31, 2014", 
        "location": {
            "contact": {
                "email": "bernhard.ludvik@meduniwien.ac.at", 
                "last_name": "Bernhard Ludvik, MD"
            }, 
            "facility": {
                "address": {
                    "city": "Vienna", 
                    "country": "Austria", 
                    "zip": "1090"
                }, 
                "name": "Medical University of Vienna"
            }, 
            "investigator": [
                {
                    "last_name": "Bernhard Ludvik, MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Gerhard Prager, MD", 
                    "role": "Principal Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Austria"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Link Between Obesity And Vitamin D in Bariatric Patients With Omega-loop Bypass Surgery: a Randomized Controlled, Double-blinded Clinical Supplementation Trial", 
        "overall_contact": {
            "email": "maria.luger@meduniwien.ac.at", 
            "last_name": "Maria Luger, MSc"
        }, 
        "overall_official": {
            "affiliation": "Division of Endocrinology & Metabolism, Department of Internal Medicine III, Medical University of Vienna", 
            "last_name": "Bernhard Ludvik, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Austria: Federal Office for Safety in Health Care", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "25-hydroxy vitamin D levels after 24 weeks measured in intervention and placebo group, adjusting for the baseline value as covariate", 
            "measure": "25-hydroxy vitamin D levels", 
            "safety_issue": "No", 
            "time_frame": "24 weeks postoperatively"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02092376"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Medical University of Vienna", 
            "investigator_full_name": "Maria Luger", 
            "investigator_title": "Maria Luger, MSc", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Number of patients reaching 25-hydroxyvitamin D levels above 75 nmol/l", 
                "measure": "Prevalence of sufficient vitamin D", 
                "safety_issue": "No", 
                "time_frame": "24 weeks postoperatively"
            }, 
            {
                "description": "Prevalence of vitamin D deficiency", 
                "measure": "Prevalence of vitamin D deficiency", 
                "safety_issue": "No", 
                "time_frame": "24 weeks postoperatively"
            }, 
            {
                "description": "Prevalence of Co-morbidities", 
                "measure": "Co-morbidities", 
                "safety_issue": "No", 
                "time_frame": "24 weeks postoperatively"
            }, 
            {
                "description": "Change in prescribed medication", 
                "measure": "Prescribed medication", 
                "safety_issue": "No", 
                "time_frame": "24 weeks postoperatively"
            }, 
            {
                "description": "Change in body weight and body composition by bioelectrical impedance analysis", 
                "measure": "Body weight, body composition", 
                "safety_issue": "No", 
                "time_frame": "24 weeks postoperatively"
            }, 
            {
                "description": "Change of vital signs (blood pressure)", 
                "measure": "Blood pressure", 
                "safety_issue": "No", 
                "time_frame": "24 weeks postoperatively"
            }, 
            {
                "description": "Change in laboratory parameters compared to baseline: vitamin D status, bone turnover markers, calcium homeostasis, parathyroid hormone, inflammation, insulin resistance", 
                "measure": "Laboratory parameters", 
                "safety_issue": "No", 
                "time_frame": "24 weeks postoperatively"
            }, 
            {
                "description": "Prevalence of depression symptoms assessed by Beck Depression Inventory Questionnaire", 
                "measure": "Depression symptoms", 
                "safety_issue": "No", 
                "time_frame": "24 weeks postoperatively"
            }, 
            {
                "description": "Assessment of bone mineral density and total body fat content by DEXA", 
                "measure": "Bone mineral density and body fat content", 
                "safety_issue": "No", 
                "time_frame": "24 weeks postoperatively"
            }, 
            {
                "description": "Measurement of liver stiffness and fat content by FibroScan and CAP", 
                "measure": "Liver condition", 
                "safety_issue": "No", 
                "time_frame": "24 weeks postoperatively"
            }, 
            {
                "description": "Dietary assessment will be documented with a 5-day food record to calculate vitamin D intake and the Mediterranean Score (questionnaire with calculated score)", 
                "measure": "Dietary assessment", 
                "safety_issue": "No", 
                "time_frame": "24 weeks postoperatively"
            }, 
            {
                "description": "Association between vitamin D, gut microbiota and surgery-induced weight loss, by collecting stool samples", 
                "measure": "Gut microbiota composition", 
                "safety_issue": "No", 
                "time_frame": "24 weeks postoperatively"
            }, 
            {
                "description": "For instance, for the purposes of describing adipose depot vitamin D concentrations and expression of enzymes in subcutaneous, visceral adipose and liver tissue samples will be collected during the omega loop gastric bypass surgery. Furthermore, the liver tissue samples should be used in addition for a histological examination as extended diagnostics (NAFLD/ NASH).", 
                "measure": "Vitamin D in adipose and liver tissue", 
                "safety_issue": "No", 
                "time_frame": "during surgery"
            }
        ], 
        "source": "Medical University of Vienna", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Maria Luger", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Pharmacokinetics Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}